Home / Pentostatin / United States
US ATC L01XX08 · updated 2 Nov 2026
Pentostatin shortage in United States
Is there a Pentostatin shortage in United States?
Yes. As of 2 Nov 2026, 1 Pentostatin product is reported short in United States, the first since 27 Aug 2026. No return date has been given. Main reason: other.
Also short in Germany, Italy, Ireland. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01) | Hospira, Inc., a Pfizer Company | 27 Aug 2026 | not given | Other |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).